Minodronic acid monohydrate

CAS No. 155648-60-5

Minodronic acid monohydrate( —— )

Catalog No. M21947 CAS No. 155648-60-5

Minodronic acid monohydrate is an farnesyl diphosphate synthase inhibitor that acts as a bone resorption inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 38 In Stock
25MG 67 In Stock
50MG 91 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Minodronic acid monohydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Minodronic acid monohydrate is an farnesyl diphosphate synthase inhibitor that acts as a bone resorption inhibitor.
  • Description
    Minodronic acid monohydrate is an farnesyl diphosphate synthase inhibitor that acts as a bone resorption inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Transferase
  • Recptor
    Farnesyl diphosphate synthase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    155648-60-5
  • Formula Weight
    340.16
  • Molecular Formula
    C9H14N2O8P2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O.OC(Cc1cnc2ccccn12)(P(O)(O)=O)P(O)(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Airoldi A , Bettoni P , Donnola M , et al. Crystal structure of zwitterionic 3-(2-hydroxy-2-phosphonato-2-phosphonoethyl)imidazo[1, 2-a]-pyridin-1-ium monohydrate (minodronic acid monohydrate): A redetermination[J]. Acta Crystallogr E Crystallogr Commun, 2015.
molnova catalog
related products
  • Ervogastat

    Ervogastat is a potent and well-tolerated diacylglycerol acyltransferase 2 inhibitor.

  • AZD3988

    AZD3988 is an orally active and highly potent inhibitor of diacylglycerol acyltransferase-1 (DGAT-1) for the study of diabetes and obesity.

  • 3,5-Dinitrocatechol

    OR-486 is an inhibitor of catechol-O-methyl-transferase(COMT) and can be used to prepare the molybdenum (VI)- 3,5-Dinitrocatechol complex.